Congratulation! A radiocontrast agent drug was granted by the US FDA!
UPDATE : 2020/10/05
In Sep., a new achievement was reached by the professional team of Virginia Contract Research Organization Co., Ltd. (VCRO). A biotech company, which was assisted by VCRO, was granted a 505(b)1 product IND clinical-go for a radiocontrast agent from the FDA. The professional, integrated, and local team of VCRO successfully helped customers to achieve the next step of product commercialization.